암성 통증의 약물치료
Medical Treatment of Cancer Pain: Drug Therapy according to Guidelines Will Improve the Quality of Life of Cancer Patients
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Cancer pain is the most common and troublesome symptom for cancer patients. The more the cancer patient gets to the end of the life, the worse the pain. There are many clinical practice guidelines for cancer pain, and most pain can be controlled with appropriate medication by guideline. We would like to summarize various domestic and foreign clinical practice guidelines relatively simply. According to the clinical practice guidelines, medical treatment including opioids will greatly improve the quality of life of cancer patients.
Abstract
Cancer pain is the most common and troublesome symptom for cancer patients. The more the cancer patient gets to the end of the life, the worse the pain. There are many clinical practice guidelines for cancer pain, and most pain can be controlled with appropriate medication by guideline. We would like to summarize various domestic and foreign clinical practice guidelines relatively simply. According to the clinical practice guidelines, medical treatment including opioids will greatly improve the quality of life of cancer patients.
참고문헌 (13)
- van den Beuken-van Everdingen MH1, "Prevalence of pain in patients with cancer: a systematic review of the past 40 years", Ann Oncol, 18, pp.1437~1449 (2007)[DOI]
- Deandrea S, "Prevalence of undertreatment in cancer pain. A review of published literature", Ann Oncol, 19, pp.1985~1991 (2008)[DOI]
- Ministry of Health & Welfare, "Cancer pain management guideline", Ministry of Health & Welfare, ~ (2017)
- "NCCN clinical practice guidelines in Oncology; Adult Cancer Pain Version I" (2018)[URL]
- Paice JA, "Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline", J Clin Oncol, 34, pp.3325~3345 (2016)[DOI]
- Ripamonti CI, "Management of cancer pain: ESMO clinical practice guidelines", Ann Oncol, 23(Suppl 7), pp.vii139~vii154 (2012)[DOI]
- Ferreira-Valente MA, "Validity of four pain intensity rating scales", Pain, 152, pp.2399~2404 (2011)[DOI]
- Taverner T, "Neuropathic pain in people with cancer (part 2): pharmacological and non-pharmacological management", Int J Palliat Nurs, 21, pp.380~384 (2015)[DOI]
- Bennet MI, "Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review", Palliat Med, 25, pp.553~559 (2011)[DOI]
- Kane CM, "Opioids combined with antidepressants or antiepileptic drugs for cancer pain: systematic review", Palliat Med, 32, pp.276~286 (2018)[DOI]
- Jongen JL, "The evidence for pharmacologic treatment of neuropathic cancer pain: beneficial and adverse effects", J pain symptom manage, 46, pp.581~590 (2013)[DOI]
- Mercadante SL, "A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients", Am J Hosp Palliat Care, 24, pp.13~19 (2007)[DOI]
- Vasudev NS, "Medical management of metastatic bone disease", Curr Opin Support palliat Care, 4, pp.189~194 (2010)[DOI]